Fed. Circ. Skeptical Allergan Illegally Extended Exclusivity
A Federal Circuit panel seemed doubtful Thursday that a patent covering Allergan's bowel treatment drug Viberzi should have its life cut short based on the expiration date of related patents, in...To view the full article, register now.
Already a subscriber? Click here to view full article